Literature DB >> 19754160

Copper binding to beta-2-microglobulin and its pre-amyloid oligomers.

Rapole Srikanth1, Vanessa Leah Mendoza, Juma D Bridgewater, Guanshi Zhang, Richard W Vachet.   

Abstract

Beta-2-microglobulin (beta2m) deposits as amyloid fibrils in the musculoskeletal system of patients undergoing long-term dialysis treatment as a result of kidney failure. Previous work has shown that Cu(II) binding causes beta2m to organize into nativelike dimers and tetramers that precede amyloid formation. Cu(II) is then released from higher-order oligomers before mature Cu(II)-free amyloid fibrils are formed. While some of the Cu(II)-induced structural changes that enable beta2m self-assembly are starting to be revealed, the details of how the Cu(II) binding site evolves from the monomer to the dimers and tetramers are not known. Here, we report results from three mass spectrometry (MS)-based methods that provide insight into the changing Cu-beta2m interactions. We find that monomeric beta2m binds Cu(II) via the N-terminal amine, the amide of Gln2, His31, and Asp59. In the dimer and tetramer, Asp59 is no longer bound to Cu(II), but the other residues still comprise a well-defined albeit weaker binding site that is better able to release Cu(II). Consistent with this is the observation that a fraction of the tetrameric species no longer binds Cu(II) at this weakened binding site, which agrees with a previous report that suggested the tetramer as the first Cu(II)-free oligomer. Our results also provide some insight into structural changes caused by Cu(II) binding that facilitate oligomer formation. Specifically, binding by Asp59 in the monomer requires significant movement of this residue, and we propose that this repositioning is important for establishing a pair of dimer-stabilizing salt bridges between this residue and Lys19. We also find evidence that Cu(II) binding in the N-terminal region of the monomer repels Arg3, which likely allows this residue to form a pair of dimer-stabilizing salt bridges with Glu16. Overall, our measurements suggest that the previously proposed conformational switch caused by Cu(II) binding includes not only a cis-trans isomerization at Pro32 but also the repositioning of residues that are critical for the formation of new electrostatic interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754160      PMCID: PMC2766818          DOI: 10.1021/bi901172y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  43 in total

1.  The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition.

Authors:  Giuliana Verdone; Alessandra Corazza; Paolo Viglino; Fabio Pettirossi; Sofia Giorgetti; Palma Mangione; Alessia Andreola; Monica Stoppini; Vittorio Bellotti; Gennaro Esposito
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

Review 2.  The galvanization of beta-amyloid in Alzheimer's disease.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Mapping Cu(II) binding sites in prion proteins by diethyl pyrocarbonate modification and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometric footprinting.

Authors:  Kefeng Qin; Ying Yang; Peter Mastrangelo; David Westaway
Journal:  J Biol Chem       Date:  2001-11-06       Impact factor: 5.157

4.  Development of a methodology based on metal-catalyzed oxidation reactions and mass spectrometry to determine the metal binding sites in copper metalloproteins.

Authors:  Jihyeon Lim; Richard W Vachet
Journal:  Anal Chem       Date:  2003-03-01       Impact factor: 6.986

5.  Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin.

Authors:  Catherine M Eakin; Frank J Attenello; Charles J Morgan; Andrew D Miranker
Journal:  Biochemistry       Date:  2004-06-22       Impact factor: 3.162

6.  Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse beta-amyloid peptide.

Authors:  Teresa Kowalik-Jankowska; Monika Ruta; Kornelia Wiśniewska; Leszek Łankiewicz; Marcin Dyba
Journal:  J Inorg Biochem       Date:  2004-06       Impact factor: 4.155

7.  Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis.

Authors:  James Villanueva; Masaru Hoshino; Hidenori Katou; József Kardos; Kazuhiro Hasegawa; Hironobu Naiki; Yuji Goto
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

8.  Using mass spectrometry to study copper-protein binding under native and non-native conditions: beta-2-microglobulin.

Authors:  Jihyeon Lim; Richard W Vachet
Journal:  Anal Chem       Date:  2004-07-01       Impact factor: 6.986

9.  Formation of a copper specific binding site in non-native states of beta-2-microglobulin.

Authors:  Catherine M Eakin; Jefferson D Knight; Charles J Morgan; Michael A Gelfand; Andrew D Miranker
Journal:  Biochemistry       Date:  2002-08-27       Impact factor: 3.162

10.  Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties.

Authors:  Chi H Trinh; David P Smith; Arnout P Kalverda; Simon E V Phillips; Sheena E Radford
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

View more
  28 in total

1.  DE-loop mutations affect beta2 microglobulin stability, oligomerization, and the low-pH unfolded form.

Authors:  Carlo Santambrogio; Stefano Ricagno; Matteo Colombo; Alberto Barbiroli; Francesco Bonomi; Vittorio Bellotti; Martino Bolognesi; Rita Grandori
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

2.  Covalent Labeling with Diethylpyrocarbonate: Sensitive to the Residue Microenvironment, Providing Improved Analysis of Protein Higher Order Structure by Mass Spectrometry.

Authors:  Patanachai Limpikirati; Xiao Pan; Richard W Vachet
Journal:  Anal Chem       Date:  2019-06-13       Impact factor: 6.986

3.  Covalent labeling with isotopically encoded reagents for faster structural analysis of proteins by mass spectrometry.

Authors:  Yuping Zhou; Richard W Vachet
Journal:  Anal Chem       Date:  2013-09-23       Impact factor: 6.986

4.  Top-down study of β2-microglobulin deamidation.

Authors:  Xiaojuan Li; Xiang Yu; Catherine E Costello; Cheng Lin; Peter B O'Connor
Journal:  Anal Chem       Date:  2012-06-29       Impact factor: 6.986

5.  Validation of metal-binding sites in macromolecular structures with the CheckMyMetal web server.

Authors:  Heping Zheng; Mahendra D Chordia; David R Cooper; Maksymilian Chruszcz; Peter Müller; George M Sheldrick; Wladek Minor
Journal:  Nat Protoc       Date:  2013-12-19       Impact factor: 13.491

6.  Investigating Therapeutic Protein Structure with Diethylpyrocarbonate Labeling and Mass Spectrometry.

Authors:  Nicholas B Borotto; Yuping Zhou; Stephen R Hollingsworth; John E Hale; Eric M Graban; Robert C Vaughan; Richard W Vachet
Journal:  Anal Chem       Date:  2015-10-01       Impact factor: 6.986

Review 7.  Covalent labeling-mass spectrometry with non-specific reagents for studying protein structure and interactions.

Authors:  Patanachai Limpikirati; Tianying Liu; Richard W Vachet
Journal:  Methods       Date:  2018-04-07       Impact factor: 3.608

8.  Protein-Ligand Affinity Determinations Using Covalent Labeling-Mass Spectrometry.

Authors:  Tianying Liu; Tyler M Marcinko; Richard W Vachet
Journal:  J Am Soc Mass Spectrom       Date:  2020-06-22       Impact factor: 3.109

9.  Structure of the preamyloid dimer of beta-2-microglobulin from covalent labeling and mass spectrometry.

Authors:  Vanessa Leah Mendoza; Kwasi Antwi; Mario A Barón-Rodríguez; Cristian Blanco; Richard W Vachet
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

10.  Label scrambling during CID of covalently labeled peptide ions.

Authors:  Nicholas B Borotto; Nicholas Degraan-Weber; Yuping Zhou; Richard W Vachet
Journal:  J Am Soc Mass Spectrom       Date:  2014-07-24       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.